drugset / Trial / NCT04555694
Comparing Treatment of Dry Eye With Intracanalicular Dexamethasone, Restasis, and/or Lotemax
RandomizedParallel-groupOpen-labelTreatment
Summary
This 6 month study seeks to compare the use of Intracanalicular Dexamethasone in conjunction with Restasis (cyclosporine ophthalmic emulsion) for the treatment of signs and symptoms of dry eye disease as compared to Restasis with Lotemax (loteprednol etabonate ophthalmic suspension 0.5%) and Restasis monotherapy.
Timeline
- Start
- 2020-10-01
- Primary completion
- 2022-02-16
- Completion
- 2022-02-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Cyclosporine | Peptide | — | Other |
| Comparator | Dexamethasone | Small molecule | 0.4 mg | Other |
| Comparator | Loteprednol Etabonate | Other / unclassified | 0.5 % | Other |